A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC).

被引：1
|
作者：
Funt, Samuel Aaron
Jatwani, Karan
Makris, Michelle
Regazzi, Ashley Marie
Lee, Chung-Han
Teo, Min Yuen
McHugh, Deaglan Joseph
Mccoy, Asia S.
Hettich, Grace
Wong, Phillip
Abu-Akeel, Moshen
Wolchok, Jedd D.
Merghoub, Taha
Al-Ahmadie, Hikmat
Ostrovnaya, Irina
Chaim, Joshua
Durack, Jeremy C.
Iyer, Gopa
Bajorin, Dean F.
Rosenberg, Jonathan E.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mt Sinai St Lukes & West Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4559
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study.
    Lista, Alfonso Gomez De Liano
    Romero-Laorden, Nuria
    Gajate, Pablo
    Orta-Ruiz, Alberto
    Jimenez, Jesus Garcia-Donas
    Miranda, Maria Jose
    Estevez, Sergio Vazquez
    Molins, Carmen
    Pernaut, Cristina
    Cordero, Marta Gonzalez
    Fernandez, Ovidio
    Sanchez, Jose Garcia
    Maeso, Iria Gonzalez
    Blazquez, Patricia Rodriguez
    Reig, Oscar
    Maroto-Rey, Pablo
    Martin, Almudena
    Ramirez, Ignacio
    Puente, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [2] Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma
    Agarwal, Neeraj
    Apolo, Andrea B.
    Tsao, Che-Kai
    Lee, Karen M.
    Godbold, James H.
    Soto, Rothschild
    Poole, Austin
    Gimpel-Tetra, Kiev
    Lowe, Nancy
    Oh, William K.
    Galsky, Matthew D
    ONCOLOGIST, 2014, 19 (09): : 915 - 916
  • [3] Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma
    Tsao, Che-Kai
    Agarwal, Neeraj
    Apolo, Andrea Borghese
    Lee, Karen M.
    Godbold, James H.
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [4] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Qin, Shuxia
    Yi, Lidan
    Li, Sini
    Tan, Chongqing
    Zeng, Xiaohui
    Wang, Liting
    Peng, Ye
    Wan, Xiaomin
    ADVANCES IN THERAPY, 2021, 38 (06) : 3399 - 3408
  • [5] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Shuxia Qin
    Lidan Yi
    Sini Li
    Chongqing Tan
    Xiaohui Zeng
    Liting Wang
    Ye Peng
    Xiaomin Wan
    Advances in Therapy, 2021, 38 : 3399 - 3408
  • [6] Impact of gemcitabine plus cisplatin plus ipilimumab on circulating immune cells in patients (pts) with metastatic urothelial cancer (mUC).
    Galsky, Matt D.
    Hahn, Noah M.
    Albany, Costantine
    Fleming, Mark T.
    Starodub, Alexander
    Twardowski, Przemyslaw
    Hauke, Ralph J.
    Sonpavde, Guru
    Merad, Miriam
    Gnjatic, Sacha
    Bhardwaj, Nina
    Chippada-Venkata, Uma
    Oh, William K.
    Kim-Schulze, Seunghee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer:: A pilot study
    Laack, E
    Andritzky, B
    Dürk, H
    Burkholder, I
    Edler, L
    Schuch, G
    Boeters, I
    Görn, M
    Lipp, R
    Horst, H
    Popp, J
    Hossfeld, DK
    ONKOLOGIE, 2005, 28 (12): : 647 - 650
  • [8] OVERALL SURVIVAL IN PATIENTS WITH METASTATIC UROTHELIAL CANCER BY FIRST-LINE THERAPY
    Velde, Vander N. S.
    Guerin, A.
    Ionescu-Ittu, R.
    Shi, S.
    Wu, E.
    Lin, S.
    de Ducla, S.
    Wang, J.
    Li, S.
    Derleth, C.
    Leppert, J. T.
    Liu, S.
    Shi, L.
    VALUE IN HEALTH, 2017, 20 (09) : A421 - A421
  • [9] Gemcitabine with cisplatin and nivolumab: Redefining standard of care for first-line metastatic urothelial carcinoma?
    Thomas, Vinay Mathew
    Grivas, Petros
    Agarwal, Neeraj
    MED, 2024, 5 (02): : 109 - 111
  • [10] Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?
    Miranda, Vanessa Costa
    Dib-Faria, Luiza
    Freitas Melro Braghiroli, Maria Ignez
    Sabbaga, Jorge
    Saragiotto, Daniel Fernandes
    Castro, Gilberto
    Hoff, Paulo M.
    Riechelmann, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345